These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3510455)

  • 21. Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes.
    Puentes A; García J; Vera R; López R; Suarez J; Rodríguez L; Curtidor H; Ocampo M; Tovar D; Forero M; Bermudez A; Cortes J; Urquiza M; Patarroyo ME
    Vaccine; 2004 Mar; 22(9-10):1150-6. PubMed ID: 15003642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
    PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of sporozoite-specific memory cells in mice immunized with a recombinant Plasmodium vivax circumsporozoite protein.
    Nardin EH; Barr PJ; Gibson HL; Collins WE; Nussenzweig RS; Nussenzweig V
    Eur J Immunol; 1987 Dec; 17(12):1763-7. PubMed ID: 3319650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory activity against sporozoites induced by antibodies directed against nonrepetitive regions of the circumsporozoite protein of Plasmodium vivax.
    Millet P; Chizzolini C; Wirtz RA; Bathurst I; Broderson JR; Campbell GH; Collins WE
    Eur J Immunol; 1992 Feb; 22(2):519-24. PubMed ID: 1371470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo testing of subunit vaccines against malaria sporozoites using a rodent system.
    Lal AA; de la Cruz VF; Good MF; Weiss WR; Lunde M; Maloy WL; Welsh JA; McCutchan TF
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8647-51. PubMed ID: 3479809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels.
    Carvalho LJ; Oliveira SG; Theisen M; Alves FA; Andrade MC; Zanini GM; Brígido MC; Oeuvray C; Póvoa MM; Muniz JA; Druilhe P; Daniel-Ribeiro CT
    Scand J Immunol; 2004 Apr; 59(4):363-72. PubMed ID: 15049780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites.
    Egan JE; Hoffman SL; Haynes JD; Sadoff JC; Schneider I; Grau GE; Hollingdale MR; Ballou WR; Gordon DM
    Am J Trop Med Hyg; 1993 Aug; 49(2):166-73. PubMed ID: 8357078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen.
    Fidock DA; Pasquetto V; Gras H; Badell E; Eling W; Ballou WR; Belghiti J; Tartar A; Druilhe P
    Eur J Immunol; 1997 Oct; 27(10):2502-13. PubMed ID: 9368603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.
    Nardin E; Munesinghe YD; Moreno A; Clavijo P; Calle MC; Edelman R; Davis J; Herrington D; Nussenzweig RS
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():223-7. PubMed ID: 1364202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo results suggesting that anti-sporozoite antibodies do not totally block Plasmodium falciparum sporozoite infectivity.
    Mellouk S; Mazier D; Druilhe P; Berbiguier N; Danis M
    N Engl J Med; 1986 Sep; 315(10):648. PubMed ID: 3526150
    [No Abstract]   [Full Text] [Related]  

  • 31. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B; Hundt E; Knapp B
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion.
    Sim BK; Orlandi PA; Haynes JD; Klotz FW; Carter JM; Camus D; Zegans ME; Chulay JD
    J Cell Biol; 1990 Nov; 111(5 Pt 1):1877-84. PubMed ID: 2229177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Model multiple antigenic and homopolymeric peptides from non-repetitive sequences of malaria merozoite proteins elicit biologically irrelevant antibodies.
    Ramasamy R; Kanagaratnam R; Chandanie PD; Kulachelvy K; Ramasamy MS; Dharmasena PM
    Biochim Biophys Acta; 1999 Jan; 1453(1):115-25. PubMed ID: 9989251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.
    Sim BK; Carter JM; Deal CD; Holland C; Haynes JD; Gross M
    Exp Parasitol; 1994 May; 78(3):259-68. PubMed ID: 7512929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.
    Silvie O; Rubinstein E; Franetich JF; Prenant M; Belnoue E; Rénia L; Hannoun L; Eling W; Levy S; Boucheix C; Mazier D
    Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers.
    Calle JM; Nardin EH; Clavijo P; Boudin C; Stüber D; Takacs B; Nussenzweig RS; Cochrane AH
    J Immunol; 1992 Oct; 149(8):2695-701. PubMed ID: 1401909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine.
    Ballou WR; Hoffman SL; Sherwood JA; Hollingdale MR; Neva FA; Hockmeyer WT; Gordon DM; Schneider I; Wirtz RA; Young JF
    Lancet; 1987 Jun; 1(8545):1277-81. PubMed ID: 2884410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein.
    Malik A; Egan JE; Houghten RA; Sadoff JC; Hoffman SL
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3300-4. PubMed ID: 1707538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax.
    Nardin EH; Nussenzweig V; Nussenzweig RS; Collins WE; Harinasuta KT; Tapchaisri P; Chomcharn Y
    J Exp Med; 1982 Jul; 156(1):20-30. PubMed ID: 7045272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.